616 related articles for article (PubMed ID: 28507026)
1. Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System.
Seki SM; Stevenson M; Rosen AM; Arandjelovic S; Gemta L; Bullock TNJ; Gaultier A
J Immunol; 2017 Jun; 198(12):4607-4617. PubMed ID: 28507026
[TBL] [Abstract][Full Text] [Related]
2. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
3. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
4. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Mony JT; Khorooshi R; Owens T
Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
[TBL] [Abstract][Full Text] [Related]
5. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
6. The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.
Lee SY; Goverman JM
J Immunol; 2013 May; 190(10):4991-9. PubMed ID: 23562810
[TBL] [Abstract][Full Text] [Related]
7. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
8. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
9. Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice.
Zhang H; Bi J; Yi H; Fan T; Ruan Q; Cai L; Chen YH; Wan X
Immunol Cell Biol; 2017 Aug; 95(7):593-600. PubMed ID: 28202908
[TBL] [Abstract][Full Text] [Related]
10. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
[TBL] [Abstract][Full Text] [Related]
11. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis.
Ponomarev ED; Novikova M; Yassai M; Szczepanik M; Gorski J; Dittel BN
J Immunol; 2004 Aug; 173(3):1587-95. PubMed ID: 15265886
[TBL] [Abstract][Full Text] [Related]
12. Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity.
Wang LM; Zhang Y; Li X; Zhang ML; Zhu L; Zhang GX; Xu YM
Brain Behav Immun; 2018 Feb; 68():44-55. PubMed ID: 28962999
[TBL] [Abstract][Full Text] [Related]
13. IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.
Huber M; Heink S; Pagenstecher A; Reinhard K; Ritter J; Visekruna A; Guralnik A; Bollig N; Jeltsch K; Heinemann C; Wittmann E; Buch T; Prazeres da Costa O; Brüstle A; Brenner D; Mak TW; Mittrücker HW; Tackenberg B; Kamradt T; Lohoff M
J Clin Invest; 2013 Jan; 123(1):247-60. PubMed ID: 23221338
[TBL] [Abstract][Full Text] [Related]
14. Alteration of the cytokine signature by various TLR ligands in different T cell populations in MOG37-50 and MOG35-55-induced EAE in C57BL/6 mice.
Steckner C; Weber A; Mausberg AK; Heininger M; Opdenhövel F; Kieseier BC; Hartung HP; Hofstetter HH
Clin Immunol; 2016 Sep; 170():22-30. PubMed ID: 27233983
[TBL] [Abstract][Full Text] [Related]
15. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation By Subchronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.
Yang EJ; Stokes JV; Kummari E; Eells J; Kaplan BL
Toxicol Sci; 2016 May; 151(1):35-43. PubMed ID: 26822306
[TBL] [Abstract][Full Text] [Related]
17. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN
PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166
[TBL] [Abstract][Full Text] [Related]
18. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
19. Experimental autoimmune encephalomyelitis development is aggravated by Candida albicans infection.
Fraga-Silva TF; Mimura LA; Marchetti CM; Chiuso-Minicucci F; França TG; Zorzella-Pezavento SF; Venturini J; Arruda MS; Sartori A
J Immunol Res; 2015; 2015():635052. PubMed ID: 25969836
[TBL] [Abstract][Full Text] [Related]
20. CCR7 on CD4
Belikan P; Bühler U; Wolf C; Pramanik GK; Gollan R; Zipp F; Siffrin V
J Immunol; 2018 Apr; 200(8):2554-2562. PubMed ID: 29549177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
